Monday, April 17, 2017

Cancer Gene Therapy - Table of Contents alert Volume 24 Issue 4

If you are unable to see the message below, click here to view.
Cancer Gene Therapy


Volume 24, Issue 4 (April 2017)

In this issue
Original Articles

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed

Original Articles


In vitro exploration of a myeloid-derived suppressor cell line as vehicle for cancer gene therapy

S Denies, F Combes, C Ghekiere, S Mc Cafferty, L Cicchelero and N N Sanders

Cancer Gene Ther 2017 24: 149-155; advance online publication, November 18, 2016; 10.1038/cgt.2016.60

Abstract | Full Text

Promising gene delivery system based on polyethylenimine-modified silica nanoparticles

M Babaei, H Eshghi, Kh Abnous, M Rahimizadeh and M Ramezani

Cancer Gene Ther 2017 24: 156-164; advance online publication, January 27, 2017; 10.1038/cgt.2016.73

Abstract | Full Text

Therapeutic vaccination based on side population cells transduced by the granulocyte–macrophage colony-stimulating factor gene elicits potent antitumor immunity

C Sakamoto, H Kohara, H Inoue, M Narusawa, Y Ogawa, L Hirose-Yotsuya, S Miyamoto, Y Matsumura, K Yamada, A Takahashi and K Tani

Cancer Gene Ther 2017 24: 165-174; advance online publication, January 13, 2017; 10.1038/cgt.2016.80

Abstract | Full Text

Baculovirus directly activates murine NK cells via TLR9

T Moriyama, T Suzuki, M O Chang, M Kitajima and H Takaku

Cancer Gene Ther 2017 24: 175-179; advance online publication, February 10, 2017; 10.1038/cgt.2017.2

Abstract | Full Text

Adenovirus-mediated TIPE2 overexpression inhibits gastric cancer metastasis via reversal of epithelial–mesenchymal transition

H Yin, X Huang, M Tao, Q Hu, J Qiu, W Chen, J Wu and Y Xie

Cancer Gene Ther 2017 24: 180-188; advance online publication, February 10, 2017; 10.1038/cgt.2017.3

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cancer Gene Therapy. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

nature publishing group

No comments: